Member Info for Bluelight

No ones shorting this Dave, certainly not me. I've never shorted a stock in my life, it's the lowest form of investing. You should however reign in your emotions and language, as that isn't acceptable on here of in life in general.

Lol Dave, another teenage keyboard warrior I see. Your language has been reported buddy.

I hear Boohoo underpaid their staff, maybe ncyt should do an rns to assure the market our staff are paid correctly. Come on people get real.

Why issue a pointless rns with something everyone already knows, silly. Rns is for new info that will have a material impact on the share price, it's not a tool to hold the hand of an individual investor. Use some common sense.

Yeah i don't think it will be an outright position. I'd be surprised if they were even allowed to take positions on stocks as thats speculative, when they make their money from being the broker not a trader as such. Who knows though.

I imagine spreadex has bought to cover the increasing shorts from individuals who use it. In effect spreadex will have no exposure. Dont see it as a positive or negative, maybe slightly negative as theyve bought but prices have still fallen.

Approvals aren't sales. I'd be worried about the ability to sell given the seemingly shoddy at best approach to getting to market. Some of the competitors in the field have excellent sales and distribution channels. Turning up 6m late to a party and still expecting fresh cake is optimistic.

Ask yourself this, if the product is so much better than the rest out there why is it not certified, and why has it sold zero when the major players have sold hundreds of millions already and locked in contracts into next year. The answer to that is the reason why the share price is where it is. People can harp on all day long about being undervalued, but as of today its sold nothing, and as each day goes on its market is being taken by other players.

Mcap at £5 would be c£300m for them. Shows you how the market doesnt know how to value things properly (also why I think the winners of the covid race will be taken over at much higher multiples than at present). I'd take the view personally of putting fair value as 2yrs times sales. That's just my view though, with Aim volatility it could be anything. But that's actual sales, not projections prior to authorisation. You'd have to discount that significantly until actual sales show how it will pan out.

I'm not convinced on that. Rightly or wrongly GDR is now tagged as a covid stock, and I would suspect 99% of the people invested are in it for that reason. Also given the poor track record on sales performance i'd take a more pessimistic view on achieved sales. Not to forget costs will need to be upfront so serious profit wont come for at least 6m after sales get rolling full steam. That said all serious 'covid' stocks, GDR included look cheap right now, the markets underestimating the longevity of testing sales in my view. Needs a sector wide catalyst though, I don't see an approval being that catalyst.

I wouldn't bank on being valued at multiples of sales. NCYT has sold £150m worth of tests already, and increasing monthly, and yet its mcap is still only 180m. Markets often dont value it as you would think.

Gees Owls you are like a dog with a bone. Of course it's a last resort, its hardly going to be a first resort. 'Sheffield getting enhanced support as it is high on the list of cities at risk of local lockdown'. Basically after Leicester sheffield is 'one of the most ikely' cities To go into local lockdown, likely not definitely. As cases pick up I believe it will, you may believe differently, that's your prerogative.

Worth bearing in mind too that recent director buys have been in the 300-340 range. Whilst they wont necessarily have any additional info, they are obviously happy with that price making them money in the future. Also telling that its been quiet on that front for a month or two. Directors cant buy if news is pending and they are privy to ongoing negotiations etc.

Its interesting actually as the whole area is high on a national level. Bradford, Barnsley and Rotherham all in the top 10 of the country. Not sure why, must be idiots ignoring advice. Mind you the parks seem packed so doesn't surprise me its picking up again.

Council are considering it owls, its in the sheffield star, you can find it online. Basically if people dont start obeying social distancing it will happen. Also the rotherham story is in there too. Sheffield has one of the highest rates per population in the country now, although i think part of that is due to the hospitals being specialised in it.

There is so much Jam for NCYT to hoover up that I feel like Paddington Bear in a Mr Kiplings Cake factory.

Just as an update... I live in Sheffield and the council are now warning it is likely we will be put into a local shutdown again soon. Also the entire town of Rotherham will be tested regardless of symptoms. This isn't going away people, now is the time to get in for the next rally.

Its not a covif testing company, its a diagnostics company. Agreed its the majority of its business right now. Who says that even with a vaccine that means no more tests? Their are flu jabs, but millions of people still get flu every dear. the vaccine isn't a cure, and from what ive read recently at best it gives you some protection for a few months, but isnt a guarantee. I don't see any let up in demand for at least 2 to 3 years myself, and if it becomes ingrained in society like the flu then who's to say the market wont be there for the long term unfortunately.

I'd be surprised of the investors from the other covid companies don't start losing faith in them and moving in here. The dust is settling and its clear who the winner is. Not much point being in the also rans, they've missed their opportunity now, or at least the opportunity for significant scale.

520 was just people piling in on the dream. profit taking whacked it down. Now for some covid stocks that dream is just that (GDR etc). For NCYT they've made it a reality, you cant argue with the revenue and profit numbers really, for me 500p is probably fair value given the numbers coming out. Doesnt mean we are trading there right now, hence why I bought back in. If it were 500p I wouldn't buy, at 250p its a buy all day long. Trick of making money is buy when people dont price a share correctly, and also to sell it when they price it too high. Sounds simple I know, but most private investors simply trade on price movements, buy when it goes up, sell when it goes down, no more thought than that. Just need patience. I bought here originally at 100p, sold on the spike, and bought back in at 250p. I dont trade on others views, simply on my own interpretations.